What are you searching for…

The Baker Company, Inc. has appointed Dr. Kara Held to the position of Science Director to advise product development, marketing, and sales efforts.

The Baker Company, Inc., the pioneer in air containment, contamination control, and controlled environments solutions, has appointed Dr. Kara Held to the position of Science Director to advise product development, marketing, and sales efforts. Dr. Held brings a unique blend of laboratory and managerial experience, most recently as Lab Manager and Safety Officer of the Harvard Stem Cell Institute.

As Science Director, Dr. Held will bring a scientific perspective to a broad range of initiatives both inside and outside of Baker, helping to communicate the breadth and use of Baker solutions. In addition to working with the sales force to assist in application selling, she will be a key contributor to a content marketing strategy focused on customer needs and applications. As an advisor to engineering personnel, Dr. Held will help translate customer needs into actionable product requirements, as well as improve upon the microbiological and performance testing of all Baker products.

“As the life sciences continue to evolve, Baker is following suit,” said Dan Eagleson, Senior Vice President. “We are excited to bring more scientific knowledge in house and know it will allow us to better serve our Baker and Baker Ruskinn customers.” Baker and Baker Ruskinn solutions work together to create optimal environments for scientific research and clinical care:

  • Baker’s high-performing clean air and containment equipment provide unparalleled user and product protection for a variety of applications.
  • Baker’s incubation solutions, which include the Baker Ruskinn line, offer user-defined, physiologically-relevant environments for normoxic, hypoxic, and anoxic applications in cell biology, stem cell, and regenerative medicine.

Dr. Held holds a Ph.D. in Cell and Molecular Biology from the University of Vermont and completed post-doctoral studies at Yale University School of Medicine. She has published articles in Methods in Molecular Biology, Frontiers in Pharmacology, Gut, Proceedings of the National Academy of Sciences, and Cellular Signalling.

About Baker

The Baker Company has long been identified as the pioneer in the field of biological safety with an unparalleled passion for helping its customers advance science, discovery and clinical care. The company was first established in 1949 in response to a growing need to protect hospital workers from infectious diseases and the dangerous process of drug preparation. As solutions for air containment and contamination control have evolved over the years, Baker has been at the forefront of design and innovation, always believing that there are no shortcuts and that there should be no minimum standards applied to the solutions that they supply. In 2011, Baker acquired Ruskinn Technology Ltd., the world’s leading supplier of gas-controlled, anaerobic and modified atmosphere workstations for use in medical microbiology, cell biology, cancer research, molecular medicine and stem cell laboratories.